Sema4 Holdings

$2.17 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Sema4 Holdings

Sema4 Holdings Corp, formerly CM Life Sciences Inc., is a patient-centered health intelligence company, which is focused on advancing healthcare through data-driven insights. The Company applies artificial intelligence (AI) and machine learning to clinical and genomic data to build models of human health and defining individualized health trajectories. The Company’s health intelligence platform, Centrellis enables users to generate complete understanding of disease and wellness and to provide science-driven solutions to the pressing medical needs. Its products include Noninvasive Prenatal Select, Expanded Carrier Screen, Natalis Newborn Screen and Sema4 Signal Oncology Solutions. Noninvasive Prenatal Select is a blood test for insight into the user’s baby health from nine weeks into pregnancy. Expanded Carrier Screen is a carrier screen for inherited conditions. Natalis Newborn Screen is a home test that provides insight into user’s baby health by screening childhood diseases.

Stock Analysis

last close $2.17
1-mo return 36.1%
3-mo return 39.1%
avg daily vol. 1.05M
52-week high 11.9
52-week low 1.11
market cap. $751M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $202M
inst own. 36.7%
baraka

Subscribe now for daily local and international financial news

Subscribe